These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Chemotherapy of malignant melanoma using DTIC]. Zaumseil RP, Fiedler H, Lübbe D. Dermatol Monatsschr; 1977 Nov; 163(11):905-14. PubMed ID: 590586 [No Abstract] [Full Text] [Related]
3. [Chemotherapy of malignant melanoma. Results of a controlled clinical trial comparing vincristine + dacarbazin (DTIC) with and without duborimycin (author's transl)]. Chauvergne J, Clavel B, Klein T, Pommatau E. Bull Cancer; 1978 Nov; 65(2):107-9. PubMed ID: 359067 [Abstract] [Full Text] [Related]
4. [The role of radiation therapy in the primary treatment of malignant melanoma]. Scherer E. Haematol Blood Transfus; 1978 Nov; 21():277-83. PubMed ID: 83952 [No Abstract] [Full Text] [Related]
5. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results. Rudolf Z, Plesnicar S. Anticancer Res; 1982 Nov; 2(1-2):37-9. PubMed ID: 7051959 [Abstract] [Full Text] [Related]
9. [Phase II study of decarbazine (DTIC) in malignant melanoma. DTIC Research Group]. Ishihara K. Gan To Kagaku Ryoho; 1986 May 15; 13(5):1940-5. PubMed ID: 3707154 [Abstract] [Full Text] [Related]
11. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. Bedikian AY, Millward M, Pehamberger H, Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey P, Kirkwood JM, Haluska FG, Oblimersen Melanoma Study Group. J Clin Oncol; 2006 Oct 10; 24(29):4738-45. PubMed ID: 16966688 [Abstract] [Full Text] [Related]
12. [Modern trends in the therapy of malignant melanoblastoma (author's transl)]. Richter J, Duchková H, Rus J, Kubíková M. Cas Lek Cesk; 1976 Nov 12; 115(45):1385-9. PubMed ID: 1000546 [No Abstract] [Full Text] [Related]
14. Vulvar melanoma: is there a role for sentinel lymph node biopsy? de Hullu JA, Hollema H, Hoekstra HJ, Piers DA, Mourits MJ, Aalders JG, van der Zee AG. Cancer; 2002 Jan 15; 94(2):486-91. PubMed ID: 11905414 [Abstract] [Full Text] [Related]
16. [Adjuvant chemotherapy of malignant melanoma with DTIC. Lack of effect in stage I. Possible improvement of the prognosis for survival in stage IIb]. Garbe C, Guenther-Eymann K, Stadler R, Orfanos CE. Hautarzt; 1988 Apr 15; 39(4):205-12. PubMed ID: 3384660 [Abstract] [Full Text] [Related]
18. [Cutaneous malignant melanomas. Reflections based upon 26 cases seen in the Cocody teaching Hospital, Abidjan (author's transl)]. Allangba K, Djibo W, Lambin Y, Kouassi JC. Chirurgie; 1979 Apr 15; 105(9):808-11. PubMed ID: 231504 [No Abstract] [Full Text] [Related]
19. [Treatment of advanced malignant melanoma with DTIC]. Jassem J, Kopacz A, Wojszwiłło-Geppert E. Pol Tyg Lek; 1979 Feb 19; 34(8):293-5. PubMed ID: 441041 [No Abstract] [Full Text] [Related]
20. Serum VEGF-C is associated with metastatic site in patients with malignant melanoma. Vihinen PP, Hilli J, Vuoristo MS, Syrjänen KJ, Kähäri VM, Pyrhönen SO. Acta Oncol; 2007 Feb 19; 46(5):678-84. PubMed ID: 17562445 [Abstract] [Full Text] [Related] Page: [Next] [New Search]